PDB Short entry for 2FDD HEADER HYDROLASE 13-DEC-05 2FDD TITLE CRYSTAL STRUCTURE OF HIV PROTEASE D545701 BOUND WITH GW0385 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GAG-POL POLYPROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PROTEASE; COMPND 5 EC: 3.4.23.16; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HIV PROTEASE, INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR R.X.XU REVDAT 4 20-OCT-21 2FDD 1 REMARK SEQADV REVDAT 3 24-FEB-09 2FDD 1 VERSN REVDAT 2 21-MAR-06 2FDD 1 JRNL REVDAT 1 21-FEB-06 2FDD 0 JRNL AUTH J.F.MILLER,C.W.ANDREWS,M.BRIEGER,E.S.FURFINE,M.R.HALE, JRNL AUTH 2 M.H.HANLON,R.J.HAZEN,I.KALDOR,E.W.MCLEAN,D.REYNOLDS, JRNL AUTH 3 D.M.SAMMOND,A.SPALTENSTEIN,R.TUNG,E.M.TURNER,R.X.XU, JRNL AUTH 4 R.G.SHERRILL JRNL TITL ULTRA-POTENT P1 MODIFIED ARYLSULFONAMIDE HIV PROTEASE JRNL TITL 2 INHIBITORS: THE DISCOVERY OF GW0385. JRNL REF BIOORG.MED.CHEM.LETT. V. 16 1788 2006 JRNL REFN ISSN 0960-894X JRNL PMID 16458505 JRNL DOI 10.1016/J.BMCL.2006.01.035 REMARK 2 REMARK 2 RESOLUTION. 1.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 32332 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1926 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1516 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 302 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.65 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2FDD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-FEB-06. REMARK 100 THE DEPOSITION ID IS D_1000035742. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-MAR-00 REMARK 200 TEMPERATURE (KELVIN) : 98 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32651 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.580 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 4.600 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 12.00 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : 0.05100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 59.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.43700 REMARK 200 R SYM FOR SHELL (I) : 0.43700 REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.58450 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 19.79225 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 59.37675 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4880 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 MET B 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 35 45.36 -97.62 REMARK 500 ASP B 35 45.21 -97.98 REMARK 500 CYS B 67 -113.19 62.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 385 B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FDE RELATED DB: PDB REMARK 900 WILD TYPE HIV PROTEASE BOUND WITH GW0385 DBREF 2FDD A 1 99 GB P03368 POL_HV1PV 500 598 DBREF 2FDD B 1 99 GB P03368 POL_HV1PV 500 598 SEQADV 2FDD MET A 0 GB P03368 INITIATING METHIONINE SEQADV 2FDD ILE A 10 GB P03368 LEU 509 ENGINEERED MUTATION SEQADV 2FDD GLN A 19 GB P03368 LEU 518 ENGINEERED MUTATION SEQADV 2FDD ARG A 20 GB P03368 LYS 519 ENGINEERED MUTATION SEQADV 2FDD ASP A 35 GB P03368 GLU 534 ENGINEERED MUTATION SEQADV 2FDD ILE A 36 GB P03368 MET 535 ENGINEERED MUTATION SEQADV 2FDD ASN A 37 GB P03368 SER 536 ENGINEERED MUTATION SEQADV 2FDD ILE A 46 GB P03368 MET 545 ENGINEERED MUTATION SEQADV 2FDD VAL A 50 GB P03368 ILE 549 ENGINEERED MUTATION SEQADV 2FDD VAL A 54 GB P03368 ILE 553 ENGINEERED MUTATION SEQADV 2FDD VAL A 62 GB P03368 ILE 561 ENGINEERED MUTATION SEQADV 2FDD PRO A 63 GB P03368 LEU 562 ENGINEERED MUTATION SEQADV 2FDD VAL A 71 GB P03368 ALA 570 ENGINEERED MUTATION SEQADV 2FDD ALA A 82 GB P03368 VAL 581 ENGINEERED MUTATION SEQADV 2FDD MET A 90 GB P03368 LEU 589 ENGINEERED MUTATION SEQADV 2FDD MET B 0 GB P03368 INITIATING METHIONINE SEQADV 2FDD ILE B 10 GB P03368 LEU 509 ENGINEERED MUTATION SEQADV 2FDD GLN B 19 GB P03368 LEU 518 ENGINEERED MUTATION SEQADV 2FDD ARG B 20 GB P03368 LYS 519 ENGINEERED MUTATION SEQADV 2FDD ASP B 35 GB P03368 GLU 534 ENGINEERED MUTATION SEQADV 2FDD ILE B 36 GB P03368 MET 535 ENGINEERED MUTATION SEQADV 2FDD ASN B 37 GB P03368 SER 536 ENGINEERED MUTATION SEQADV 2FDD ILE B 46 GB P03368 MET 545 ENGINEERED MUTATION SEQADV 2FDD VAL B 50 GB P03368 ILE 549 ENGINEERED MUTATION SEQADV 2FDD VAL B 54 GB P03368 ILE 553 ENGINEERED MUTATION SEQADV 2FDD VAL B 62 GB P03368 ILE 561 ENGINEERED MUTATION SEQADV 2FDD PRO B 63 GB P03368 LEU 562 ENGINEERED MUTATION SEQADV 2FDD VAL B 71 GB P03368 ALA 570 ENGINEERED MUTATION SEQADV 2FDD ALA B 82 GB P03368 VAL 581 ENGINEERED MUTATION SEQADV 2FDD MET B 90 GB P03368 LEU 589 ENGINEERED MUTATION SEQRES 1 A 100 MET PRO GLN ILE THR LEU TRP GLN ARG PRO ILE VAL THR SEQRES 2 A 100 ILE LYS ILE GLY GLY GLN GLN ARG GLU ALA LEU LEU ASP SEQRES 3 A 100 THR GLY ALA ASP ASP THR VAL LEU GLU ASP ILE ASN LEU SEQRES 4 A 100 PRO GLY ARG TRP LYS PRO LYS ILE ILE GLY GLY VAL GLY SEQRES 5 A 100 GLY PHE VAL LYS VAL ARG GLN TYR ASP GLN VAL PRO ILE SEQRES 6 A 100 GLU ILE CYS GLY HIS LYS VAL ILE GLY THR VAL LEU VAL SEQRES 7 A 100 GLY PRO THR PRO ALA ASN ILE ILE GLY ARG ASN LEU MET SEQRES 8 A 100 THR GLN ILE GLY CYS THR LEU ASN PHE SEQRES 1 B 100 MET PRO GLN ILE THR LEU TRP GLN ARG PRO ILE VAL THR SEQRES 2 B 100 ILE LYS ILE GLY GLY GLN GLN ARG GLU ALA LEU LEU ASP SEQRES 3 B 100 THR GLY ALA ASP ASP THR VAL LEU GLU ASP ILE ASN LEU SEQRES 4 B 100 PRO GLY ARG TRP LYS PRO LYS ILE ILE GLY GLY VAL GLY SEQRES 5 B 100 GLY PHE VAL LYS VAL ARG GLN TYR ASP GLN VAL PRO ILE SEQRES 6 B 100 GLU ILE CYS GLY HIS LYS VAL ILE GLY THR VAL LEU VAL SEQRES 7 B 100 GLY PRO THR PRO ALA ASN ILE ILE GLY ARG ASN LEU MET SEQRES 8 B 100 THR GLN ILE GLY CYS THR LEU ASN PHE HET 385 B 501 96 HETNAM 385 (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL [(1S,2R)-3- HETNAM 2 385 [(1,3-BENZODIOXOL-5-YLSULFONYL)(ISOBUTYL)AMINO]-2- HETNAM 3 385 HYDROXY-1-{4-[(2-METHYL-1,3-THIAZOL-4-YL) HETNAM 4 385 METHOXY]BENZYL}PROPYL]CARBAMATE FORMUL 3 385 C33 H41 N3 O10 S2 FORMUL 4 HOH *302(H2 O) HELIX 1 1 GLY A 86 THR A 91 1 6 HELIX 2 2 GLY B 86 THR B 91 1 6 SHEET 1 A 4 GLN A 2 THR A 4 0 SHEET 2 A 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 A 4 THR A 96 ASN A 98 -1 N THR A 96 O ASN B 98 SHEET 4 A 4 GLN B 2 THR B 4 -1 O ILE B 3 N LEU A 97 SHEET 1 B 8 LYS A 43 GLY A 49 0 SHEET 2 B 8 GLY A 52 ILE A 66 -1 O VAL A 56 N LYS A 45 SHEET 3 B 8 HIS A 69 VAL A 77 -1 O VAL A 71 N ILE A 64 SHEET 4 B 8 VAL A 32 LEU A 33 1 N LEU A 33 O LEU A 76 SHEET 5 B 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 B 8 ILE A 10 ILE A 15 -1 N ILE A 13 O ARG A 20 SHEET 8 B 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 C 8 LYS B 43 GLY B 49 0 SHEET 2 C 8 GLY B 52 ILE B 66 -1 O VAL B 56 N LYS B 45 SHEET 3 C 8 HIS B 69 VAL B 77 -1 O VAL B 77 N ARG B 57 SHEET 4 C 8 VAL B 32 LEU B 33 1 N LEU B 33 O LEU B 76 SHEET 5 C 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 C 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 C 8 ILE B 10 ILE B 15 -1 N ILE B 13 O ARG B 20 SHEET 8 C 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 SITE 1 AC1 34 ASP A 25 GLY A 27 ALA A 28 ASP A 29 SITE 2 AC1 34 ASP A 30 GLY A 48 GLY A 49 VAL A 50 SITE 3 AC1 34 ILE A 72 PRO A 81 ALA A 82 ILE A 84 SITE 4 AC1 34 HOH A 174 HOH A 378 ASP B 25 GLY B 27 SITE 5 AC1 34 ALA B 28 ASP B 29 ASP B 30 GLY B 48 SITE 6 AC1 34 GLY B 49 VAL B 50 ILE B 72 PRO B 81 SITE 7 AC1 34 ALA B 82 ILE B 84 HOH B 502 HOH B 503 SITE 8 AC1 34 HOH B 505 HOH B 538 HOH B 545 HOH B 582 SITE 9 AC1 34 HOH B 635 HOH B 637 CRYST1 55.382 55.382 79.169 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018056 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018056 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012631 0.00000